Renub

    United States Proton Therapy Market has potential to surpass US$ 16 Billion by 2024
    01 May, 2018

    Get Free Customization in This Report

    United States is the global market leader in proton therapy technology. It started its first center Loma Linda (LLUMC) in early 1990. In 2010, it has eight proton therapy operational centers and further this figure increased more than three times in 2017. Moreover there are many proton therapy centers in pipelines (under-construction and planning phase). 

    Proton therapy is one of the popular techniques in particle therapy that has many advantages over other like carbon, photon and ions. It delivers the proton exactly on the spot without affecting the surrounding area or very minimal damage of surrounding parts. Therefore it has mitigate the side effect to the great extent than other particle therapy techniques. Proton therapy is gaining prominence due to its non-invasive technique and highly effectiveness. 

     

    Request a free sample copy of the report: https://www.renub.com/contactus.php


    Rising Cancer Incidence in United States Propels the Growth of Proton Therapy Market

    Cancer incidence in United States is reaching at tipping point. In 2016, 1.6 Million people diagnosed with cancer and it is projected to increase in coming future. The cancer mortality rate in United States is also very high; around 595,690 people died from the cancer in 2016. Moreover there are many cancers that are very complicated and several difficulties are occurred during conventional surgical therapy. Proton therapy is advance and effective therapy that perform better results over conventional therapy. The number of proton therapy center in United States is increasing with rapid pace to make this technology accessible to large number of patients. Although diagnosed cancer patients number are too high than the actual number of cancer patients treated with proton therapy. According to Renub Research, United States Proton Therapy Market has potential to surpass US$ 16 Billion by the end of 2024.

    united-states-proton-therapy-market


    Advancement of Proton Therapy Technology will further add the Procedural Effectiveness 

    The research and development of proton therapy has been happening since last four decade and technology has been commercially in operation since last three decades. In current outlook manufacturer developed compact cyclotron, advanced delivery systems. The introduction of robotics in proton therapy systems increased efficiency in the management of patient transport, patient treatment positioning, treatment appliances, and imaging systems. Moreover the paradigm-shift of large proton therapy equipment into compact tools creates investment feasibility for industry players and mitigates some sort of entry barriers. Currently many small hospital and medical institutions are also investing in proton therapy to make it widely accessible.

     

    Client can Purchase this Report in Sections from below link:

    Access full Research: https://www.renub.com/united-states-proton-therapy-market-and-forecast-reimbursement-policy-patients-treated-at-proton-therapy-centers-1045-p.php


    Proton Therapy provides Treatment Opportunities for Recurrent Cancer

    As per the historical facts about cancer, recurrence cancer has been very difficult to treat; because large number of cancer patients is not opting for surgery. In such situation, the patients with reoccurrence cancer offered palliative options as a last resort to manage pain. Proton therapy is effective in managing recurrence kind of cancer because it has ability to target a pinpoint of tumor and completely destroy it without affecting nearby healthy tissues. Proton therapy established high credibility and acceptance among patients to treat high-risk cancer disease. 

     

    Key Topics Covered: 

    1.    Executive Summary

    2.    Market (Actual & Potential) – United States Proton Therapy Market (2009 – 2024)

    2.1    Actual Proton Therapy Market

    2.2    Potential Proton Therapy Market

    3.    Number of Patients – United States Proton Therapy (2009 – 2024)

    3.1    Actual Numbers

    3.2    Potential Numbers

    4.    Cancer Types – Patients Number in United States Proton Therapy (2009 – 2024)

    4.1    Central Nervous System Tumors

    4.2    Intraocular Melanomas Cancer

    4.3    Pituitary Neoplasms Cancer

    4.4    Base of Skull / Axial Skeleton Cancer

    4.5    Head and Neck Cancer

    4.6    Lung Cancer

    4.7    Retroperitoneal Sarcoma Cancer

    4.8    Pediatric Cancer Cases (Up to Age 18)

    4.9    Gastrointestinal Tract Cancer

    4.10    Urinary Tract Cancer

    4.11    By Female Pelvic Organs Cancer

    4.12    Prostate Cancer

    4.13    Breast Cancer

    4.14    Other Cancer

    5.    Cancer Types – United States Proton Therapy Market (2009 – 2024)

    5.1    Central Nervous System Tumors

    5.2    Intraocular Melanomas Cancer

    5.3    Pituitary Neoplasms Cancer

    5.4    Base of Skull / Axial Skeleton Cancer

    5.5    Head and Neck Cancer

    5.6    Lung Cancer

    5.7    Retroperitoneal Sarcoma Cancer

    5.8    Pediatric Cancer (Up to Age 18)

    5.9    Gastrointestinal Tract Cancer

    5.10    Urinary Tract Cancer

    5.11    Female Pelvic Organs Cancer

    5.12    Prostate Cancer

    5.13    Breast Cancer

    5.14    Other Cancer

    6.    United States – List of Proton Therapy Centers

    6.1    Operating Proton Therapy Centers

    6.2    Under-Construction Therapy Centers

    6.3    Planning Proton Therapy Centers

    7.    By Centers – Number of Proton Therapy Patients Treated

    7.1    Loma Linda (LLUMC) Proton Therapy Center (2008 – 2016)

    7.2    UCSF – CNL Proton Therapy Center (2008 – 2015)

    7.3    Boston (NPTC) Proton Therapy Center (2008 – 2016)

    7.4    Bloomington (MPRI, 2) Proton Therapy Center (2008 – 2014)

    7.5    Houston (MD Anderson) Proton Therapy Center (2008 – 2016)

    7.6    UFPTI Jacksonville Proton Therapy Center (2008 – 2016)

    7.7    Oklahoma City (ProCure PTC) Proton Therapy Center (2009 – 2017)

    7.8    CDH Warrenville Proton Therapy Center (2010 – 2016)

    7.9    Philadelphia (Upenn) Proton Therapy Center (2011 – 2016)

    7.10    Hampton (HUPTI) Proton Therapy Center (2012 – 2016)

    7.11    New Jersey (ProCure PTC) Proton Therapy Center (2012 – 2016)

    7.12    Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 – 2016)

    7.13    St. Louis (S. Lee King PTC) Proton Therapy Center (2013 – 2016)

    7.14    Provision Center for Proton Therapy, Knoxville, TN (2014 – 2016)

    7.15    San Diego (Scripps PTC) (2014 – 2017)

    7.16    Shreveport (Willis Knighton) Proton Therapy Center (2014 – 2017)

    7.17    Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)

    7.18    Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)

    7.19    Brunswick (Laurie PC) Proton Therapy Center (2015)

    7.20    Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)

    7.21    Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)

    7.22    Phoenix (Mayo PBTC) Proton Therapy Center (2016)

    7.23    Baltimore (Maryland PTC) Proton Therapy Center (2016)

    7.24    Cincinnati (Children's PTC) Proton Therapy Center (2016)

    7.25    Orlando (Orlando Health PTC) Proton Therapy Center (2016)

    7.26    Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

    8.    Proton Therapy – Reimbursement Policies

    8.1    Proton Therapy Reimbursement Policies for Patients

    8.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

    9.    Components of a Standard Proton Therapy Center

    9.1    Proton Accelerator

    9.2    Beam Transport System

    9.3    Beam Delivery System

    9.4    Nozzle

    9.5    Treatment Planning System

    9.6    Image Viewers

    9.7    Patient Positioning System (PPS)

    9.8    Human Resource

    10.    Company Analysis (2010 – 2021)

    10.1    IBA Proton Therapy

    10.2    Varian Medical Systems

    10.3    Elekta

    11.    Driving Factors for Proton Therapy (Due to data confidentiality, driving factors have not been disclosed in this table of contents)

    11.1    Point No. 1

    11.2    Point No. 2

    12.    Challenges in Proton Therapy (Due to data confidentiality, challenges have not been disclosed in this table of contents)

    12.1    Point no. 1

    12.2    Point No. 2

     

    About Us

    Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

     

    Contact Us

    Renub Research

    Phone: +1-678-302-0700

    Email: info@renub.com

    Website: https://www.renub.com     

    Follow us on LinkedIn: https://www.linkedin.com/company/renub-research

    Related Reports